
Indoco Remedies Limited has informed the Exchange about press release dated 08-Apr-2022 titled Indoco Remedies receives USFDA approval for Lacosamide Injection USP
Filed with NSE ·

Indoco Remedies Limited has informed the Exchange about press release dated 08-Apr-2022 titled Indoco Remedies receives USFDA approval for Lacosamide Injection USP
6ix hasn’t read this filing yet.
Indoco Remedies Limited on 6ix
Follow Indoco Remedies into a list and get an email when it puts out news.
Follow Indoco Remedies